To investigate whether the activation of cGAS/STING pathway participates in the anti-tumor effect of Trabid deficiency, we treated mice inoculated with Trabid-deficient B16F10 cells with a STING inhibitor C176. The gene discussed is STING1; the disease is hyperinsulinemic hypoglycemia, familial, 4.